Cargando…
Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
Several candidates for a vaccine against Burkholderia pseudomallei, the causal bacterium of melioidosis, have been developed, and a rational approach is now needed to select and advance candidates for testing in relevant nonhuman primate models and in human clinical trials. Development of such a vac...
Autores principales: | Limmathurotsakul, Direk, Funnell, Simon G.P., Torres, Alfredo G., Morici, Lisa A., Brett, Paul J., Dunachie, Susanna, Atkins, Timothy, Altmann, Daniel M., Bancroft, Gregory, Peacock, Sharon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451926/ https://www.ncbi.nlm.nih.gov/pubmed/25992835 http://dx.doi.org/10.3201/eid2106.141480 |
Ejemplares similares
-
Clinical Definitions of Melioidosis
por: Cheng, Allen C., et al.
Publicado: (2013) -
New Insights from the 7th World Melioidosis Congress 2013
por: Schweizer, Herbert P., et al.
Publicado: (2014) -
Host Responses to Melioidosis and Tuberculosis Are Both Dominated by Interferon-Mediated Signaling
por: Koh, Gavin C. K. W., et al.
Publicado: (2013) -
Melioidosis Diagnostic Workshop, 2013
por: Hoffmaster, Alex R., et al.
Publicado: (2015) -
Gastrointestinal tract involvement in melioidosis
por: Teparrukkul, Prapit, et al.
Publicado: (2017)